Page last updated: 2024-11-04

sb 202190 and Endometrial Neoplasms

sb 202190 has been researched along with Endometrial Neoplasms in 1 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Research Excerpts

ExcerptRelevanceReference
"Endometrial carcinoma is the most common neoplasm of the female genital tract, accounting for nearly one half of all gynecologic cancers in the Western world."1.35Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase. ( Choi, KC; Leung, PC; MacCalman, CD; Park, DW, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, DW1
Choi, KC1
MacCalman, CD1
Leung, PC1

Other Studies

1 other study available for sb 202190 and Endometrial Neoplasms

ArticleYear
Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.
    Reproductive biology and endocrinology : RB&E, 2009, Aug-05, Volume: 7

    Topics: Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Endometri

2009